CASE OF GUILLAIN-BARRE´ SYNDROME IN A PATIENT WITH PULMONARY LANGERHANS CELL HYSTIOCYTOSIS
https://doi.org/10.20514/2226-6704-2019-9-5-399-402
Abstract
Langerhans cell histiocytosis is a rare disease characterized by various clinical patterns: from isolated lung lesions to severe involvement of other organs. This clinical case demonstrates a rare combination of pulmonary Langerhans cell histiocytosis and Guillain—Barre syndrome due to possible common mechanisms of the disease development mediated by the CD1A expression.
About the Authors
E. V. EfremovaRussian Federation
Elena V. Efremova
Department of General Medicine and Occupational Diseases, Medical Faculty
Ulyanovsk
A. V. Vasil’chev
Russian Federation
Ulyanovsk
A. M. Shutov
Russian Federation
Department of General Medicine and Occupational Diseases, Medical Faculty
Ulyanovsk
A. S. Podusov
Russian Federation
Department of General Medicine and Occupational Diseases, Medical Faculty
Ulyanovsk
I. Yu Troshina
Russian Federation
Department of General Medicine and Occupational Diseases, Medical Faculty
Ulyanovsk
A. A. Timofeev
Russian Federation
Department of General Medicine and Occupational Diseases, Medical Faculty
Ulyanovsk
References
1. Russian Society of Neurology. Guillain-Barre syndrome in adults. Clinical guidelines. 2016; 23 р. [in Russian].
2. Kaida K, Ariga T., Yu R.K. Antiganglioside antibodies and their pathophysiological effects on Guillain–Barre syndrome and related disorders — A review. Glycobiology. 2009; 19(7): 676–692. doi: 10.1093/glycob/cwp027.
3. Liu H., Xing Y., Guo Y. et al. Polymorphisms in exon 2 of CD1 genes are associated with susceptibility to Guillain-Barre syndrome. J Neurol Sci. 2016; 369: 39-42. doi: 10.1016/j.jns.2016.07.029.
4. Cencioni M.T., Notturno F., Caporale C.M. T cell response in acute motor axonal neuropathy. Int J Immunopathol Pharmacol. 2009; 22(4): 1043-50. doi:10.1177/039463200902200420
5. Zinn D.J., Chakraborty R., Allen C.E. Langerhans Cell Histiocytosis: Emerging Insights and Clinical Implications.Oncology (Williston Park). 2016 ;30(2): 122-32, 139.
6. Grois N., Prayer D., Prosch H. et al. Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain. 2005; 128(4): 829–38. doi:10.1093/brain/awh403
7. Guo F., Zhang Y.B. Clinical features and prognosis of patients with Guillain-Barre and acute transverse myelitis overlap syndrome. Clin Neurol Neurosurg. 2019; 181: 127-132. doi: 10.1016/j.clineuro.2019.04.014.
Review
For citations:
Efremova E.V., Vasil’chev A.V., Shutov A.M., Podusov A.S., Troshina I.Yu., Timofeev A.A. CASE OF GUILLAIN-BARRE´ SYNDROME IN A PATIENT WITH PULMONARY LANGERHANS CELL HYSTIOCYTOSIS. The Russian Archives of Internal Medicine. 2019;9(5):399-402. https://doi.org/10.20514/2226-6704-2019-9-5-399-402